- MidCap Business Credit Closes Revolving Line of Credit for Allied Dairy Products, Inc.
- Callodine Group Announces Acquisition of Gordon Brothers Finance Company, LLC
- MidCap Financial Closes $44mm Senior Secured Credit Facility to AleraCare
- CIT Leads $162 Million Financing for Texas Solar Plant
- Rosenthal Broadens Its Financing Offerings to Span Both Recourse and Non-Recourse Factoring
CNH Finance Closes More than 40 Facilities During 2021
February 16, 2022
By CNH Finance
CNH Finance is pleased to announce it closed more than 40 facilities during 2021 totaling over $160 million new commitments. These results signify its commitment to long-term stabilized portfolio growth through building new client relationships and supporting growth in existing partnerships.
New and existing partnership servicing includes supporting growth and asset-based lending capital needs of healthcare providers in the long-term care, skilled nursing, hospital, behavioral health, and other healthcare provider sectors. The CNHF Commercial and Industrial transaction portfolio remains robust as well.
CNHF continues to invest heavily in the development of the tech-enabled platform with AI, robotic processing and real time risk monitoring tools facilitating immediate feedback to our portfolio management team and furthering our high-quality borrower experience.
CNHF is proud of its achievements in 2021, and with portfolio activity recovering to beyond to pre-pandemic levels, look forward to a building on our momentum in 2022 and beyond.
A few of CNHF’s successful 2021 financings include:
- $5 million AR revolving letter of credit to an orthopedic medical device manufacturer
- $10 million AR revolving letter of credit specialty Rx cost containment company
- $20 million AR revolving letters of credit and term loans for hospitals and disproportionate share transactions
- $10 million AR revolving letter of credit for a health information and electronic record company
- $17 million AR revolving letter of credit for skilled nursing facilities
- $7.5 million AR revolving letter of credit for a health economics and outcome research company